193 related articles for article (PubMed ID: 21069290)
1. Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease.
Fraisse A; Butrous G; Taylor MB; Oakes M; Dilleen M; Wessel DL
Intensive Care Med; 2011 Mar; 37(3):502-9. PubMed ID: 21069290
[TBL] [Abstract][Full Text] [Related]
2. Effects of escalating doses of sildenafil on hemodynamics and gas exchange in children with pulmonary hypertension and congenital cardiac defects.
Raja SG; Danton MD; MacArthur KJ; Pollock JC
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):203-7. PubMed ID: 17418732
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil therapy for pulmonary hypertension before and after pediatric congenital heart surgery.
Palma G; Giordano R; Russolillo V; Cioffi S; Palumbo S; Mucerino M; Poli V; Vosa C
Tex Heart Inst J; 2011; 38(3):238-42. PubMed ID: 21720460
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of sildenafil pressurized metered dose inhalers as a vasodilator in umbilical blood vessels of chicken egg embryos.
Sawatdee S; Hiranphan P; Laphanayos K; Srichana T
Eur J Pharm Biopharm; 2014 Jan; 86(1):90-7. PubMed ID: 24036276
[TBL] [Abstract][Full Text] [Related]
5. Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial.
Parker JD; Bart BA; Webb DJ; Koren MJ; Siegel RL; Wang H; Malhotra B; Jen F; Glue P
Crit Care Med; 2007 Aug; 35(8):1863-8. PubMed ID: 17522570
[TBL] [Abstract][Full Text] [Related]
6. Perioperative sildenafil therapy for pulmonary hypertension in infants undergoing congenital cardiac defect closure.
El Midany AA; Mostafa EA; Azab S; Hassan GA
Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):963-8. PubMed ID: 23985411
[TBL] [Abstract][Full Text] [Related]
7. STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension.
Barst RJ; Beghetti M; Pulido T; Layton G; Konourina I; Zhang M; Ivy DD;
Circulation; 2014 May; 129(19):1914-23. PubMed ID: 24637559
[TBL] [Abstract][Full Text] [Related]
8. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost AE; Engel PJ; Kramer MR; Burgess G; Collings L; Cossons N; Sitbon O; Badesch DB;
Ann Intern Med; 2008 Oct; 149(8):521-30. PubMed ID: 18936500
[TBL] [Abstract][Full Text] [Related]
9. Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.
Wirostko BM; Tressler C; Hwang LJ; Burgess G; Laties AM
BMJ; 2012 Feb; 344():e554. PubMed ID: 22354598
[TBL] [Abstract][Full Text] [Related]
10. Oral sildenafil to control pulmonary hypertension after congenital heart surgery.
Peiravian F; Amirghofran AA; Borzouee M; Ajami GH; Sabri MR; Kolaee S
Asian Cardiovasc Thorac Ann; 2007 Apr; 15(2):113-7. PubMed ID: 17387192
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension.
Barst RJ; Ivy DD; Gaitan G; Szatmari A; Rudzinski A; Garcia AE; Sastry BK; Pulido T; Layton GR; Serdarevic-Pehar M; Wessel DL
Circulation; 2012 Jan; 125(2):324-34. PubMed ID: 22128226
[TBL] [Abstract][Full Text] [Related]
12. Substantially increased sildenafil bioavailability after sublingual administration in children with congenital heart disease: two case reports.
Carls A; Winter J; Enderle Y; Burhenne J; Gorenflo M; Haefeli WE
J Med Case Rep; 2014 May; 8():171. PubMed ID: 24885923
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and hemodynamic responses to oral sildenafil during invasive testing in children with pulmonary hypertension.
Apitz C; Reyes JT; Holtby H; Humpl T; Redington AN
J Am Coll Cardiol; 2010 Apr; 55(14):1456-62. PubMed ID: 20359596
[TBL] [Abstract][Full Text] [Related]
14. Postoperative use of oral sildenafil in pediatric patients with congenital heart disease.
Uhm JY; Jhang WK; Park JJ; Seo DM; Yun SC; Yun TJ
Pediatr Cardiol; 2010 May; 31(4):515-20. PubMed ID: 20054528
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil for the treatment of pulmonary hypertension in pediatric patients.
Huddleston AJ; Knoderer CA; Morris JL; Ebenroth ES
Pediatr Cardiol; 2009 Oct; 30(7):871-82. PubMed ID: 19705181
[TBL] [Abstract][Full Text] [Related]
16. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.
Schulze-Neick I; Hartenstein P; Li J; Stiller B; Nagdyman N; Hübler M; Butrous G; Petros A; Lange P; Redington AN
Circulation; 2003 Sep; 108 Suppl 1():II167-73. PubMed ID: 12970227
[TBL] [Abstract][Full Text] [Related]
17. Intermittent intravenous sildenafil for pulmonary hypertension management in neonates and infants.
Stultz JS; Puthoff T; Backes C; Nahata MC
Am J Health Syst Pharm; 2013 Mar; 70(5):407-13. PubMed ID: 23413163
[TBL] [Abstract][Full Text] [Related]
18. Sildenafil exposure and hemodynamic effect after Fontan surgery.
Tunks RD; Barker PC; Benjamin DK; Cohen-Wolkowiez M; Fleming GA; Laughon M; Li JS; Hill KD
Pediatr Crit Care Med; 2014 Jan; 15(1):28-34. PubMed ID: 24201857
[TBL] [Abstract][Full Text] [Related]
19. Effects of sildenafil on prognosis in patients with pulmonary hypertension after left-sided valvular surgery.
Jiang G; Li B; Zhang G; Xu E; Liu Y; Xu Z
Heart Lung Circ; 2014 Jul; 23(7):680-5. PubMed ID: 24613188
[TBL] [Abstract][Full Text] [Related]
20. Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension.
Ramani GV; Park MH
Drug Des Devel Ther; 2010 May; 4():61-70. PubMed ID: 20531962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
